Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) has been approved by the Shanghai Stock Exchange for a simple process for additional issuance in 2024.

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) announced that on March 12, 2025, the company received the Shanghai Stock Exchange's review opinion on the company's application for issuing shares to specific parties through a simple process for the year 2024: In accordance with the Securities Law, the Administrative Measures for the Registration of Securities Issued by Listed Companies, the Shanghai Stock Exchange's Rules for the Review of Securities Issuance and Listing of Listed Companies, and other relevant laws, regulations, and provisions, Eyebright Medical Technology (Beijing) Co., Ltd. 's application for issuing shares to specific parties meets the issuance conditions, listing conditions, and information disclosure requirements. The Exchange will submit the application to the China Securities Regulatory Commission after receiving your company's application documents.